Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM)

Until recently, PET was regarded as a luxurious way of performing myocardial perfusion scintigraphy, with excellent image quality and diagnostic capabilities that hardly justified the additional cost and procedural effort. Quantitative perfusion PET was considered a major improvement over standard qualitative imaging, because it allows the measurement of parameters not otherwise available, but for many years its use was confined to academic and research settings. In recent years, however, several factors have contributed to the renewal of interest in quantitative perfusion PET, which has become a much more readily accessible technique due to progress in hardware and the availability of dedicated and user-friendly platforms and programs. In spite of this evolution and of the growing evidence that quantitative perfusion PET can play a role in the clinical setting, there are not yet clear indications for its clinical use. Therefore, the Cardiovascular Committee of the European Association of Nuclear Medicine, starting from the experience of its members, decided to examine the current literature on quantitative perfusion PET to (1) evaluate the rationale for its clinical use, (2) identify the main methodological requirements, (3) identify the remaining technical difficulties, (4) define the most reliable interpretation criteria, and finally (5) tentatively delineate currently acceptable and possibly appropriate clinical indications. The present position paper must be considered as a starting point aiming to promote a wider use of quantitative perfusion PET and to encourage the conception and execution of the studies needed to definitely establish its role in clinical practice.

[1]  M. Phelps,et al.  Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  D E Kuhl,et al.  Comparison of rubidium-82 positron emission tomography and thallium-201 SPECT imaging for detection of coronary artery disease. , 1991, The American journal of cardiology.

[3]  S. Kumita,et al.  Impact of time-of-flight on qualitative and quantitative analyses of myocardial perfusion PET studies using 13N-ammonia , 2014, Journal of Nuclear Cardiology.

[4]  R. Slart,et al.  Unilateral and Multilateral Congenital Coronary‐Pulmonary Fistulas in Adults: Clinical Presentation, Diagnostic Modalities, and Management With a Brief Review of the Literature , 2014, Clinical cardiology.

[5]  Ran Klein,et al.  Quantification of myocardial blood flow and flow reserve: Technical aspects , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[6]  M. Pencina,et al.  Improved Cardiac Risk Assessment With Noninvasive Measures of Coronary Flow Reserve , 2011, Circulation.

[7]  Martin A Lodge,et al.  Human Biodistribution and Radiation Dosimetry of 82Rb , 2010, The Journal of Nuclear Medicine.

[8]  Hans L Hillege,et al.  Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial Perfusion Reserve in Patients with Ischemic Heart Disease , 2009, Journal of Nuclear Medicine.

[9]  M. Lubberink,et al.  Hybrid Imaging Using Quantitative H215O PET and CT-Based Coronary Angiography for the Detection of Coronary Artery Disease , 2013, The Journal of Nuclear Medicine.

[10]  Osamu Manabe,et al.  Repeatability of Rest and Hyperemic Myocardial Blood Flow Measurements with 82Rb Dynamic PET , 2008, Journal of Nuclear Medicine.

[11]  Proceedings of the cardiac PET summit meeting 12 may 2014: Cardiac PET and SPECT instrumentation , 2015, Journal of Nuclear Cardiology.

[12]  T J Spinks,et al.  Generation of myocardial factor images directly from the dynamic oxygen-15-water scan without use of an oxygen-15-carbon monoxide blood-pool scan. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  S. Nesterov,et al.  PET: Is myocardial flow quantification a clinical reality? , 2012, Journal of Nuclear Cardiology.

[14]  M. Yacoub,et al.  Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson–Fabry disease , 2013, European journal of heart failure.

[15]  P. Kolh,et al.  2014 ESC/EACTS guidelines on myocardial revascularization. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[16]  O. Rimoldi,et al.  Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  M. Phelps,et al.  A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  M. D. Di Carli,et al.  Quantitative 82Rb PET/CT: Development and Validation of Myocardial Perfusion Database , 2007, Journal of Nuclear Medicine.

[19]  Parthiban Arumugam,et al.  Impact of point spread function modeling and time-of-flight on myocardial blood flow and myocardial flow reserve measurements for rubidium-82 cardiac PET , 2014, Journal of Nuclear Cardiology.

[20]  B. Khandheria Noninvasive imaging. , 2005, Journal of the American College of Cardiology.

[21]  I. Olivotto,et al.  Microvascular Dysfunction, Myocardial Ischemia, and Progression to Heart Failure in Patients with Hypertrophic Cardiomyopathy , 2009, Journal of cardiovascular translational research.

[22]  F. Girolami,et al.  Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy. , 2006, Journal of the American College of Cardiology.

[23]  Kris Thielemans,et al.  Extracting a respiratory signal from raw dynamic PET data that contain tracer kinetics , 2013 .

[24]  M. Schwaiger,et al.  Assessment of diagnostic performance of quantitative flow measurements in normal subjects and patients with angiographically documented coronary artery disease by means of nitrogen-13 ammonia and positron emission tomography. , 1998, Journal of the American College of Cardiology.

[25]  F. Bengel,et al.  Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  W. MacIntyre,et al.  Clinical outcome of cardiac patients with negative thallium-201 SPECT and positive rubidium-82 PET myocardial perfusion imaging. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  R. Blankstein,et al.  Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease , 2015, Circulation.

[28]  I. Olivotto,et al.  Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.

[29]  T. Dill Contraindications to magnetic resonance imaging , 2008, Heart.

[30]  A. Sinusas Does a shortened hyperemia with regadenoson stress pose a concern for quantitative Rb-82 PET imaging? Optimization of regadenoson PET imaging. , 2015, JACC. Cardiovascular imaging.

[31]  G. Hutchins,et al.  Interobserver and interstudy variability of myocardial blood flow and flow-reserve measurements with nitrogen 13 ammonia-labeled positron emission tomography , 1995, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[32]  R. Boellaard,et al.  Impact of anatomical and functional severity of coronary atherosclerotic plaques on the transmural perfusion gradient: a [15O]H2O PET study. , 2013, European heart journal.

[33]  J. De Sutter,et al.  Myocardial Perfusion Reserve After a PET-Driven Revascularization Procedure: A Strong Prognostic Factor , 2011, The Journal of Nuclear Medicine.

[34]  B. Tamarappoo,et al.  Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease. , 2014, Seminars in nuclear medicine.

[35]  E. Antman,et al.  ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionucl , 2003, Journal of the American College of Cardiology.

[36]  D. Neglia,et al.  Prognostic Role of Myocardial Blood Flow Impairment in Idiopathic Left Ventricular Dysfunction , 2002, Circulation.

[37]  K. Gould,et al.  Regadenoson versus dipyridamole hyperemia for cardiac PET imaging. , 2015, JACC. Cardiovascular imaging.

[38]  Georges El Fakhri,et al.  Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Assessment with 82Rb PET: Comparison with 13N-Ammonia PET , 2009, Journal of Nuclear Medicine.

[39]  M. Javadi,et al.  Prediction of Short-Term Cardiovascular Events Using Quantification of Global Myocardial Flow Reserve in Patients Referred for Clinical 82Rb PET Perfusion Imaging , 2011, The Journal of Nuclear Medicine.

[40]  G. Beller Underestimation of coronary artery disease with SPECT perfusion imaging , 2008, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[41]  Gerold Porenta,et al.  Typical chest pain and normal coronary angiogram: cardiac risk factor analysis versus PET for detection of microvascular disease. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[42]  Kathryn A. Williams,et al.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. , 2011, Journal of the American College of Cardiology.

[43]  R. Huesman,et al.  Consequences of using a simplified kinetic model for dynamic PET data. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[44]  B. Chow,et al.  CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary. , 2007, The Canadian journal of cardiology.

[45]  A. Lammertsma,et al.  Quantitative assessment of myocardial perfusion in the detection of significant coronary artery disease: cutoff values and diagnostic accuracy of quantitative [(15)O]H2O PET imaging. , 2014, Journal of the American College of Cardiology.

[46]  J. Case,et al.  Variability in normal myocardial blood flow measurements: Physiologic, methodologic, or protocol related? , 2015, Journal of Nuclear Cardiology.

[47]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[48]  Bradley T. Christian,et al.  Quantitative PET with positron emitters that emit prompt gamma rays , 1995, IEEE Trans. Medical Imaging.

[49]  R. deKemp,et al.  Biodistribution and radiation dosimetry of 82Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  P. Herrero,et al.  Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. , 1990, Circulation.

[51]  J. Case,et al.  Regadenoson pharmacologic rubidium-82 PET: A comparison of quantitative perfusion and function to dipyridamole , 2013, Journal of Nuclear Cardiology.

[52]  F. Crea,et al.  Coronary microvascular dysfunction. , 2013, The New England journal of medicine.

[53]  J. Machac,et al.  Repeatability of regional myocardial blood flow calculation in 82Rb PET imaging , 2009, BMC medical physics.

[54]  Paul Kinahan,et al.  Effect of Reconstruction Algorithms on Myocardial Blood Flow Measurement with 13N-Ammonia PET , 2007, Journal of Nuclear Medicine.

[55]  Daniel C. Lee,et al.  Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. , 2009, JACC. Cardiovascular imaging.

[56]  A. Pupi,et al.  Validation of pixel-wise parametric mapping of myocardial blood flow with 13NH3 PET in patients with hypertrophic cardiomyopathy , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[57]  R. Wahl,et al.  Quantitative assessment of myocardial blood flow--clinical and research applications. , 2014, Seminars in nuclear medicine.

[58]  Terrence D. Ruddy,et al.  Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease , 2004, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[59]  J. Yap,et al.  Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[60]  Randall C. Thompson,et al.  Radiation Dose to Patients From Cardiac Diagnostic Imaging , 2007, Circulation.

[61]  Andrew J Einstein,et al.  Effects of radiation exposure from cardiac imaging: how good are the data? , 2012, Journal of the American College of Cardiology.

[62]  D. Berman,et al.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Associa , 2009, Journal of the American College of Cardiology.

[63]  D E Kuhl,et al.  Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. , 1990, Journal of the American College of Cardiology.

[64]  B. Chow,et al.  Prognostic Value of Rubidium-82 Positron Emission Tomography in Patients After Heart Transplant , 2014, Circulation. Cardiovascular imaging.

[65]  Georges El Fakhri,et al.  Quantitative dynamic cardiac 82Rb PET using generalized factor and compartment analyses. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[66]  R. Blankstein,et al.  Association Between Coronary Vascular Dysfunction and Cardiac Mortality in Patients With and Without Diabetes Mellitus , 2012, Circulation.

[67]  Junichi Yamazaki,et al.  Guidelines for Clinical Use of Cardiac Nuclear Medicine (JCS 2010) : Digest Version , 2012 .

[68]  R. Blankstein,et al.  Coronary vascular dysfunction and prognosis in patients with chronic kidney disease. , 2012, JACC Cardiovascular Imaging.

[69]  E. Nagel,et al.  Quantification of absolute myocardial perfusion in patients with coronary artery disease: comparison between cardiovascular magnetic resonance and positron emission tomography. , 2012, Journal of the American College of Cardiology.

[70]  T. Turkington,et al.  Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography , 1996, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[71]  Josh Klein,et al.  A selection of recent original research papers , 2014, Journal of Nuclear Cardiology.

[72]  Suleman Surti,et al.  Benefit of Time-of-Flight in PET: Experimental and Clinical Results , 2008, Journal of Nuclear Medicine.

[73]  T. Bateman Advantages and disadvantages of PET and SPECT in a busy clinical practice , 2012, Journal of Nuclear Cardiology.

[74]  G. Hutchins,et al.  Sampling requirements for dynamic cardiac PET studies using image-derived input functions. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[75]  P. Slomka,et al.  Quantification of Myocardial Perfusion Reserve Using Dynamic SPECT Imaging in Humans: A Feasibility Study , 2013, The Journal of Nuclear Medicine.

[76]  S. Nesterov,et al.  Comparison of clinical non-commercial tools for automated quantification of myocardial blood flow using oxygen-15-labelled water PET/CT. , 2014, European heart journal cardiovascular Imaging.

[77]  Keiichiro Yoshinaga,et al.  What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? , 2006, Journal of the American College of Cardiology.

[78]  D. Neglia,et al.  Structural Abnormalities of the Coronary Arterial Wall—in Addition to Luminal Narrowing—Affect Myocardial Blood Flow Reserve , 2011, The Journal of Nuclear Medicine.

[79]  J. Maddahi,et al.  Cardiac PET perfusion tracers: current status and future directions. , 2014, Seminars in nuclear medicine.

[80]  A. Gavazzi,et al.  Effects of long-term treatment with carvedilol on myocardial blood flow in idiopathic dilated cardiomyopathy , 2007, Heart.

[81]  Nassir Navab,et al.  Artifacts from misaligned CT in cardiac perfusion PET/CT studies: frequency, effects, and potential solutions. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[82]  M. Lodge,et al.  Radiation Dosimetry of 82Rb in Humans Under Pharmacologic Stress , 2011, The Journal of Nuclear Medicine.

[83]  John O. Prior,et al.  Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging. , 2013, European heart journal cardiovascular Imaging.

[84]  J. Simonsen,et al.  Quantitative myocardial perfusion by O-15-water PET: individualized vs. standardized vascular territories. , 2015, European heart journal cardiovascular Imaging.

[85]  Russell D Folks,et al.  Prompt-gamma compensation in Rb-82 myocardial perfusion 3D PET/CT , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[86]  S. Moore,et al.  Clinical Myocardial Perfusion PET/CT* , 2007, Journal of Nuclear Medicine.

[87]  K. Gould,et al.  Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve. , 2011, JACC. Cardiovascular imaging.

[88]  P. Kolh,et al.  2014 ESC/EACTS guidelines on myocardial revascularization. , 2015, Revista espanola de cardiologia.

[89]  John O. Prior,et al.  Quantification of myocardial blood flow in absolute terms using (82)Rb PET imaging: the RUBY-10 Study. , 2014, JACC. Cardiovascular imaging.

[90]  K. Gould,et al.  Does coronary flow trump coronary anatomy? , 2009, JACC. Cardiovascular imaging.

[91]  R. Blankstein,et al.  Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. , 2015, European heart journal cardiovascular Imaging.

[92]  Andy Adler,et al.  Intra- and inter-operator repeatability of myocardial blood flow and myocardial flow reserve measurements using rubidium-82 pet and a highly automated analysis program , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[93]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[94]  D. Neglia,et al.  Surgical correction of left coronary artery origin from the right coronary artery. , 2013, The Annals of thoracic surgery.

[95]  Guido Germano,et al.  Multisoftware Reproducibility Study of Stress and Rest Myocardial Blood Flow Assessed with 3D Dynamic PET/CT and a 1-Tissue-Compartment Model of 82Rb Kinetics , 2013, Journal of Nuclear Medicine.

[96]  Parthiban Arumugam,et al.  Assessment of a protocol for routine simultaneous myocardial blood flow measurement and standard myocardial perfusion imaging with rubidium-82 on a high count rate positron emission tomography system , 2012, Nuclear medicine communications.

[97]  R. Blankstein,et al.  Detection of Obstructive Coronary Artery Disease Using Regadenoson Stress and 82Rb PET/CT Myocardial Perfusion Imaging , 2013, The Journal of Nuclear Medicine.

[98]  H. Sipilä,et al.  Cardiac Positron Emission Tomography/Computed Tomography Imaging Accurately Detects Anatomically and Functionally Significant Coronary Artery Disease , 2010, Circulation.

[99]  R. Blankstein,et al.  Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization , 2015, Circulation.

[100]  Michael Fiechter,et al.  Diagnostic Value of 13N-Ammonia Myocardial Perfusion PET: Added Value of Myocardial Flow Reserve , 2012, The Journal of Nuclear Medicine.

[101]  R. Falk,et al.  Coronary microvascular dysfunction is related to abnormalities in myocardial structure and function in cardiac amyloidosis. , 2014, JACC. Heart failure.

[102]  M. Phelps,et al.  Influence of Age and Hemodynamics on Myocardial Blood Flow and Flow Reserve , 1993, Circulation.

[103]  A. L'Abbate,et al.  Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. , 1991, Journal of the American College of Cardiology.

[104]  Quantitation of the regional blood flow in the interventricular septum using positron emission tomography and nitrogen-13 ammonia , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[105]  R. Blankstein,et al.  Quantitative relationship between the extent and morphology of coronary atherosclerotic plaque and downstream myocardial perfusion. , 2011, Journal of the American College of Cardiology.

[106]  R. Kwong,et al.  Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF. , 2009, JACC. Cardiovascular imaging.

[107]  Uchechukwu Sampson,et al.  Value of vasodilator left ventricular ejection fraction reserve in evaluating the magnitude of myocardium at risk and the extent of angiographic coronary artery disease: a 82Rb PET/CT study. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[108]  M E Phelps,et al.  Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[109]  K. Gould,et al.  3: Quantitation of myocardial blood flow , 2015 .

[110]  M E Phelps,et al.  Quantitation in Positron Emission Computed Tomography: 6. Effect of Nonuniform Resolution , 1982, Journal of computer assisted tomography.

[111]  G. Heller,et al.  Proceedings of the ASNC Cardiac PET Summit, 12 May 2014, Baltimore, MD , 2015, Journal of Nuclear Cardiology.

[112]  Ran Klein,et al.  Short-term repeatability of resting myocardial blood flow measurements using rubidium-82 PET imaging , 2012, Journal of Nuclear Cardiology.

[113]  J. Declerck,et al.  Dependency of cardiac rubidium-82 imaging quantitative measures on age, gender, vascular territory, and software in a cardiovascular normal population , 2015, Journal of Nuclear Cardiology.

[114]  S. Ross,et al.  Properties and Mitigation of Edge Artifacts in PSF-Based PET Reconstruction , 2011, IEEE Transactions on Nuclear Science.

[115]  Ran Klein,et al.  Quantification of myocardial blood flow with 82Rb dynamic PET imaging , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[116]  R. Boellaard,et al.  Determinants of coronary microvascular dysfunction in symptomatic hypertrophic cardiomyopathy. , 2008, American journal of physiology. Heart and circulatory physiology.

[117]  Jeroen J. Bax,et al.  Present and future of clinical cardiovascular PET imaging in Europe—a position statement by the European Council of Nuclear Cardiology (ECNC) , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[118]  M E Phelps,et al.  Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. , 1995, Circulation.

[119]  D. J. Veldhuisen,et al.  Myocardial perfusion reserve in spared myocardium: correlation with infarct size and left ventricular ejection fraction , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[120]  V. Murthy,et al.  Non-invasive quantification of coronary vascular dysfunction for diagnosis and management of coronary artery disease , 2012, Journal of Nuclear Cardiology.

[121]  Piotr J. Slomka,et al.  Comparison of Clinical Tools for Measurements of Regional Stress and Rest Myocardial Blood Flow Assessed with 13N-Ammonia PET/CT , 2012, The Journal of Nuclear Medicine.

[122]  Frank M. Bengel,et al.  CT-based attenuation correction in 82Rb-myocardial perfusion PET–CT: incidence of misalignment and effect on regional tracer distribution , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[123]  Mehrbod S. Javadi,et al.  Definition of Vascular Territories on Myocardial Perfusion Images by Integration with True Coronary Anatomy: A Hybrid PET/CT Analysis , 2010, Journal of Nuclear Medicine.

[124]  John O. Prior,et al.  Quantification of Myocardial Blood Flow in Absolute Terms u27sing 82Rb PET Imaging: Results of RUBY-10—a multicenter study comparing ten computer analysis programs , 2014 .

[125]  Klaus Schafers,et al.  Respiratory gating of cardiac PET data in list-mode acquisition , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[126]  Sung-Cheng Huang,et al.  Absolute Quantitation of Myocardial Blood Flow in Human Subjects With or Without Myocardial Ischemia Using Dynamic Flurpiridaz F 18 PET , 2014, The Journal of Nuclear Medicine.

[127]  G. Hutchins,et al.  A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[128]  Willi A. Kalender,et al.  Dual-source cardiac computed tomography: image quality and dose considerations , 2008, European Radiology.

[129]  Benjamin C. Lee,et al.  Precision and accuracy of clinical quantification of myocardial blood flow by dynamic PET: A technical perspective , 2015, Journal of Nuclear Cardiology.

[130]  John O. Prior,et al.  Myocardial blood flow quantification by Rb-82 cardiac PET/CT: A detailed reproducibility study between two semi-automatic analysis programs , 2015, Journal of Nuclear Cardiology.

[131]  M. Schlumberger Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[132]  Juhani Knuuti,et al.  Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. , 2013, Journal of the American College of Cardiology.

[133]  A. van Rossum,et al.  Feasibility of subendocardial and subepicardial myocardial perfusion measurements in healthy normals with 15O-labeled water and positron emission tomography , 2011, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[134]  G. Fakhri,et al.  Quantitative relationship between coronary vasodilator reserve assessed by 82Rb PET imaging and coronary artery stenosis severity , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[135]  O Muzik,et al.  Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[136]  Oliver Gaemperli,et al.  Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. , 2009, Journal of the American College of Cardiology.

[137]  Michael Kreissl,et al.  Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. , 2005, Journal of the American College of Cardiology.

[138]  M E Phelps,et al.  13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.

[139]  H. Verberne,et al.  Role of risk stratification by SPECT, PET, and hybrid imaging in guiding management of stable patients with ischaemic heart disease: expert panel of the EANM cardiovascular committee and EACVI. , 2015, European heart journal cardiovascular Imaging.

[140]  Tinsu Pan,et al.  Frequent Diagnostic Errors in Cardiac PET/CT Due to Misregistration of CT Attenuation and Emission PET Images: A Definitive Analysis of Causes, Consequences, and Corrections , 2007, Journal of Nuclear Medicine.

[141]  J. Knuuti,et al.  Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (Carimas™) , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[142]  V. Dilsizian,et al.  PET-determined hyperemic myocardial blood flow: further progress to clinical application. , 2014, Journal of the American College of Cardiology.

[143]  Maurizio Conti,et al.  Advantages of Improved Time Resolution for TOF PET at Very Low Statistics , 2014, IEEE Transactions on Nuclear Science.

[144]  M. D. Di Carli,et al.  Cardiac PET perfusion: prognosis, risk stratification, and clinical management. , 2014, Seminars in nuclear medicine.

[145]  Edward P. Ficaro,et al.  Recommendations for reducing radiation exposure in myocardial perfusion imaging , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[146]  P. Todeschini,et al.  Evaluation of time of flight (TOF) and point spread function (PSF) reconstructions in the quantification of myocardial blood flow with 13N ammonia and PET: Comparison among reconstructions (reprojection, OSEM), software (PMOD and CARIMAS) and operators , 2012, 2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC).

[147]  T. Pearson New Tools for Coronary Risk Assessment: What Are Their Advantages and Limitations? , 2002, Circulation.

[148]  Arman Rahmim,et al.  Resolution modeling in PET imaging: Theory, practice, benefits, and pitfalls. , 2013, Medical physics.

[149]  A. Fischman,et al.  Comparison of positron emission tomography measurement of adenosine-stimulated absolute myocardial blood flow versus relative myocardial tracer content for physiological assessment of coronary artery stenosis severity and location. , 2009, JACC. Cardiovascular imaging.

[150]  Ronald Boellaard,et al.  Accuracy of 3-Dimensional Reconstruction Algorithms for the High-Resolution Research Tomograph , 2008, Journal of Nuclear Medicine.

[151]  N. Tamaki,et al.  Absolute quantification of myocardial blood flow , 2018, Journal of Nuclear Cardiology.

[152]  J. Votaw,et al.  Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[153]  T. Murakami,et al.  Quantitative myocardial perfusion analysis using multi-row detector CT in acute myocardial infarction , 2012, Heart.

[154]  B. Hesse,et al.  Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC) , 2010, European Journal of Nuclear Medicine and Molecular Imaging.

[155]  Raymond Kwong,et al.  Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. , 2007, Journal of the American College of Cardiology.

[156]  Julian C. Matthews,et al.  Bias in iterative reconstruction of low-statistics PET data: Benefits of a resolution model , 2009 .

[157]  Martin A Lodge,et al.  Absolute myocardial flow quantification with 82Rb PET/CT: comparison of different software packages and methods , 2013, European Journal of Nuclear Medicine and Molecular Imaging.

[158]  A Adler,et al.  Precision-controlled elution of a 82Sr/82Rb generator for cardiac perfusion imaging with positron emission tomography , 2007, Physics in Medicine and Biology.

[159]  Ran Klein,et al.  Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease? , 2012, Journal of Nuclear Cardiology.

[160]  M J Welch,et al.  Quantification of regional myocardial blood flow in vivo with H2150* , 2005 .